Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1715969

	registered interest
	date	07/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy: Waiting Lists
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of the proportion of cancer patients currently waiting more than 31 days for radiotherapy treatment.
	tabling member printed	Baroness Ritchie of Downpatrick
	uin	HL4423
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>According to the latest data, of those 10,328 cancer patients referred for first or subsequent treatment for radiotherapy in March 2024, 89.7% were treated within 31 days. The proportion of patients waiting more than 31 days for radiotherapy treatment in March 2024 was therefore 10.3%. This has decreased by 4.5% since January 2024.</p><p>We are aware of regional disparities in wait times for cancer treatment through NHS England’s data, and are considering the findings made by the Royal College of Radiologists. Tackling inequalities in outcomes, experience, and access of cancer diagnostics, including regional disparities, is a key focus of the Government. NHS England has commissioned six new cancer clinical audits in breast cancer, both primary and metastatic, as well as ovarian, pancreatic, non-Hodgkin lymphoma, and kidney cancer. These will provide timely evidence for cancer service providers of where patterns of care in England may vary, increase the consistency of access to treatments, and help stimulate improvements in cancer treatments and outcomes for patients. The first outcomes of these audits are expected in September 2024.</p><p>The Department is working closely with NHS England to make sure we have the right workforce with the right skills up and down the country. In 2023/24, NHS England invested an additional £50 million to increase the number of cancer and diagnostic specialists.</p><p>The Government is also backing the NHS Long Term Workforce Plan, with over £2.4 billion over the next five years to fund additional education and training places. The plan sets out an aim to double the number of medical school places in England to 15,000 places a year by 2031/32, and to work towards this expansion by increasing places by a third, to 10,000 a year, by 2028/29.</p><p>We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent (FTE) staff in the cancer workforce, an increase of over 13,300, or 60.7% since January 2010. Regarding clinical oncology specifically, as of January 2024, there are currently over 1,600 FTE doctors working in the speciality of clinical oncology in National Health Service trusts and other core organisations in England. This is over 30, or 2.2%, more than last year, over 300, or 27.7%, more than 2019, and over 600, 66.5%, more than in 2010. This includes over 900 FTE consultants. This is over 40, or 5.1%, more than last year, over 100, 22.0%, more than in 2019, and over 400, 80.2%, more than in 2010.</p> answering member printed Lord Markham grouped question UIN HL4424 HL4425 question first answered 13/05/2024 11:23:46 answering member 4948 label Biography information for Lord Markham
	tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1715970

	registered interest
	date	07/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: North East
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of findings from the Royal College of Radiologists, published in May, showing a regional disparity in wait times for cancer treatment in 2023, with 11 per cent of patients in England waiting more than 31 days for treatment after the decision to treat had been confirmed, compared to 19 per cent of patients in the North East and Yorkshire.
	tabling member printed	Baroness Ritchie of Downpatrick
	uin	HL4424
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>According to the latest data, of those 10,328 cancer patients referred for first or subsequent treatment for radiotherapy in March 2024, 89.7% were treated within 31 days. The proportion of patients waiting more than 31 days for radiotherapy treatment in March 2024 was therefore 10.3%. This has decreased by 4.5% since January 2024.</p><p>We are aware of regional disparities in wait times for cancer treatment through NHS England’s data, and are considering the findings made by the Royal College of Radiologists. Tackling inequalities in outcomes, experience, and access of cancer diagnostics, including regional disparities, is a key focus of the Government. NHS England has commissioned six new cancer clinical audits in breast cancer, both primary and metastatic, as well as ovarian, pancreatic, non-Hodgkin lymphoma, and kidney cancer. These will provide timely evidence for cancer service providers of where patterns of care in England may vary, increase the consistency of access to treatments, and help stimulate improvements in cancer treatments and outcomes for patients. The first outcomes of these audits are expected in September 2024.</p><p>The Department is working closely with NHS England to make sure we have the right workforce with the right skills up and down the country. In 2023/24, NHS England invested an additional £50 million to increase the number of cancer and diagnostic specialists.</p><p>The Government is also backing the NHS Long Term Workforce Plan, with over £2.4 billion over the next five years to fund additional education and training places. The plan sets out an aim to double the number of medical school places in England to 15,000 places a year by 2031/32, and to work towards this expansion by increasing places by a third, to 10,000 a year, by 2028/29.</p><p>We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent (FTE) staff in the cancer workforce, an increase of over 13,300, or 60.7% since January 2010. Regarding clinical oncology specifically, as of January 2024, there are currently over 1,600 FTE doctors working in the speciality of clinical oncology in National Health Service trusts and other core organisations in England. This is over 30, or 2.2%, more than last year, over 300, or 27.7%, more than 2019, and over 600, 66.5%, more than in 2010. This includes over 900 FTE consultants. This is over 40, or 5.1%, more than last year, over 100, 22.0%, more than in 2019, and over 400, 80.2%, more than in 2010.</p> answering member printed Lord Markham grouped question UIN HL4423 HL4425 question first answered 13/05/2024 11:23:46 answering member 4948 label Biography information for Lord Markham
	tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1715971

	registered interest
	date	07/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy: Staff
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what steps they are taking to ensure that the 15 per cent shortfall in clinical oncologists, as estimated in the Royal College of Radiologists workforce census, does not impact the operational performance of radiotherapy services.
	tabling member printed	Baroness Ritchie of Downpatrick
	uin	HL4425
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>According to the latest data, of those 10,328 cancer patients referred for first or subsequent treatment for radiotherapy in March 2024, 89.7% were treated within 31 days. The proportion of patients waiting more than 31 days for radiotherapy treatment in March 2024 was therefore 10.3%. This has decreased by 4.5% since January 2024.</p><p>We are aware of regional disparities in wait times for cancer treatment through NHS England’s data, and are considering the findings made by the Royal College of Radiologists. Tackling inequalities in outcomes, experience, and access of cancer diagnostics, including regional disparities, is a key focus of the Government. NHS England has commissioned six new cancer clinical audits in breast cancer, both primary and metastatic, as well as ovarian, pancreatic, non-Hodgkin lymphoma, and kidney cancer. These will provide timely evidence for cancer service providers of where patterns of care in England may vary, increase the consistency of access to treatments, and help stimulate improvements in cancer treatments and outcomes for patients. The first outcomes of these audits are expected in September 2024.</p><p>The Department is working closely with NHS England to make sure we have the right workforce with the right skills up and down the country. In 2023/24, NHS England invested an additional £50 million to increase the number of cancer and diagnostic specialists.</p><p>The Government is also backing the NHS Long Term Workforce Plan, with over £2.4 billion over the next five years to fund additional education and training places. The plan sets out an aim to double the number of medical school places in England to 15,000 places a year by 2031/32, and to work towards this expansion by increasing places by a third, to 10,000 a year, by 2028/29.</p><p>We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent (FTE) staff in the cancer workforce, an increase of over 13,300, or 60.7% since January 2010. Regarding clinical oncology specifically, as of January 2024, there are currently over 1,600 FTE doctors working in the speciality of clinical oncology in National Health Service trusts and other core organisations in England. This is over 30, or 2.2%, more than last year, over 300, or 27.7%, more than 2019, and over 600, 66.5%, more than in 2010. This includes over 900 FTE consultants. This is over 40, or 5.1%, more than last year, over 100, 22.0%, more than in 2019, and over 400, 80.2%, more than in 2010.</p> answering member printed Lord Markham grouped question UIN HL4423 HL4424 question first answered 13/05/2024 11:23:46 answering member 4948 label Biography information for Lord Markham
	tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1715975

	registered interest
	date	07/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Social Services: Reform
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government when they will publish their Social Care regulatory reform programme and what new protected professional medical titles they are considering introducing.
	tabling member printed	Baroness Bennett of Manor Castle
	uin	HL4374
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>There are no plans to publish a social care regulatory reform programme. However, the Government has consulted on its proposed approach to modernising the legislation of the professional health and care regulators. As part of this work, we will consider whether to make any changes to the medical titles protected in law. Any proposals will be subject to statutory consultation, and the affirmative parliamentary process.</p><p>The Anaesthesia Associates and Physician Associates Order 2024 was made on 13 March 2024, and will bring Aanaesthesia Associates and Physician Associates into regulation by the General Medical Council (GMC), under a reformed regulatory framework. We are currently working on the next phase of reform, which includes introducing a new regulatory framework for medical practitioners. The future GMC order relating to the medical profession will be drafted and published for consultation in due course.</p> answering member printed Lord Markham question first answered 13/05/2024 11:24:26 answering member 4948 label Biography information for Lord Markham
	tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1715979

	registered interest
	date	07/05/2024
	answering body	Department for Business and Trade
	answering dept id	214
	answering dept short name	Business and Trade
	answering dept sort name	Business and Trade
	hansard heading	Overseas Investment: Morocco
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government whether they will seek an investment facilitation memorandum between the UK and Morocco at the forthcoming Association Council to support UK investment in Morocco ahead of the 2030 World Cup, similar to the agreement signed with Peru ahead of the 2019 Pan-American Games.
	tabling member printed	Lord Hannan of Kingsclere
	uin	HL4402
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>The UK Government is keen to strengthen trade ties with Morocco, which deliver mutual benefits. Both countries will be hosting major football tournaments later this decade, and the Government is working closely with Morocco to share knowledge ahead of the delivery of these events.</p><p> </p><p>In 2017, HM Government signed a government-to-government agreement with Peru to support the delivery of infrastructure for the 2019 PanAmerican Games on-time and on-budget. We plan to share our experience with the Moroccan government at the forthcoming UK-Morocco Association Council.</p> answering member printed Lord Johnson of Lainston question first answered 13/05/2024 11:18:52 answering member 4949 label Biography information for Lord Johnson of Lainston
	tabling member	4905 label Biography information for Lord Hannan of Kingsclere

1715717

	registered interest
	date	02/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Private Sector
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what clinical regulation measures are in place to ensure that care and treatments provided by private medical insurers are the most appropriate for a specific patient.
	tabling member printed	Baroness Merron
	uin	HL4346
	answer	answer is ministerial correction date of answer 09/05/2024 answer text <p>Private medical insurers do not provide care or treatment. However, they do purchase services from independent sector providers who are responsible for delivering healthcare. All providers of healthcare undertaking regulated activities, as defined in Schedule 1 of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, are regulated by the Care Quality Commission, and follow a set of fundamental standards of safety and quality, while the health and care regulators are responsible for regulating health and care professionals.</p><p>Regulations 9 and 12 of the 2014 regulations set out the importance of person-centred care, and safe care and treatment. These regulations have the intention of ensuring that people using a service have care or treatment that is personalised specifically for them, preventing people from receiving unsafe care and treatment, and thereby precluding avoidable harm or risk of harm.</p> answering member printed Lord Markham question first answered 09/05/2024 16:40:38 answering member 4948 label Biography information for Lord Markham
	tabling member	347 label Biography information for Baroness Merron

1715725

	registered interest
	date	02/05/2024
	answering body	Wales Office
	answering dept id	28
	answering dept short name	Wales
	answering dept sort name	Wales
	hansard heading	Independent Commission on the Constitutional Future of Wales
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what discussions they have had with the Welsh Government on the implementation of the recommendations of the Independent Commission on the Constitutional Future of Wales.
	tabling member printed	Baroness Smith of Llanfaes
	uin	HL4356
	answer	answer is ministerial correction date of answer 09/05/2024 answer text <p>The UK Government has had no discussions with the Welsh Government on the implementation of the recommendations of the Independent Commission on the Constitutional Future of Wales.</p><p>The Commission was established by and reported to the Welsh Government. The Counsel General shared an update on the Welsh Government's consideration of the Commission’s final report with the Inter-Ministerial Standing Committee in March.</p><p>UK Government Ministers have regular discussions with Welsh Ministers on a wide range of issues. Many such discussions focus on our joint work to support economic growth and jobs in Wales, including through delivering Freeports, Investment Zones and City and Growth Deals.</p> answering member printed Lord Harlech question first answered 09/05/2024 13:30:00 answering member 4928 label Biography information for Lord Harlech
	tabling member	5023 label Biography information for Baroness Smith of Llanfaes

1715734

	registered interest
	date	02/05/2024
	answering body	Department for Environment, Food and Rural Affairs
	answering dept id	13
	answering dept short name	Environment, Food and Rural Affairs
	answering dept sort name	Environment, Food and Rural Affairs
	hansard heading	Veterinary Medicine: Northern Ireland
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government whether they have had, or intend to have, discussions with the EU regarding the implementation of a post-Brexit agreement on the supply of veterinary medicines to Northern Ireland.
	tabling member printed	Lord Taylor of Warwick
	uin	HL4366
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>The Government is committed to securing a long-term sustainable solution ahead of December 2025 that will properly support the flow of veterinary medicines into Northern Ireland from Great Britain on an enduring basis. We are determined to safeguard the supply of veterinary medicines, and we will pursue technical discussions with the EU to find a solution that removes barriers to supply; in return we are willing to provide assurances and safeguards to the EU. The Veterinary Medicines Working Group, including experts, industry representatives and elected representatives, will report back to Government on steps needed to secure supplies for the long term.</p> answering member printed Lord Douglas-Miller question first answered 13/05/2024 11:25:58 answering member 5006 label Biography information for Lord Douglas-Miller
	tabling member	1796 label Biography information for Lord Taylor of Warwick

1715737

	registered interest
	date	02/05/2024
	answering body	Department for Environment, Food and Rural Affairs
	answering dept id	13
	answering dept short name	Environment, Food and Rural Affairs
	answering dept sort name	Environment, Food and Rural Affairs
	hansard heading	Animal Welfare
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government when they will specify the relevant activities which will be proscribed under legislation to enable compliance with, and enforcement of, the Animals (Low-Welfare Activities Abroad) Act 2023.
	tabling member printed	Lord Trees
	uin	HL4369
	answer	answer is ministerial correction date of answer 10/05/2024 answer text <p>The Animals (Low-Welfare Activities Abroad) Act 2023 provides a framework for the introduction of future bans on the advertising and offering for sale, in England and Northern Ireland, of low-welfare animal activities abroad.</p><p> </p><p>Future decisions on which specific animal activities will fall in scope of the advertising ban will be evidence-based and subject to Parliamentary scrutiny. Sufficient, compelling evidence will be required to demonstrate why any specific advertising ban is needed.</p><p> </p><p>This Government continues to make animal welfare a priority and we are currently exploring a number of options to ensure progress as soon as is practicable<em>.</em></p> answering member printed Lord Douglas-Miller question first answered 10/05/2024 10:05:07 answering member 5006 label Biography information for Lord Douglas-Miller
	tabling member	4260 label Biography information for Lord Trees

1715409

	registered interest
	date	01/05/2024
	answering body	Department for Environment, Food and Rural Affairs
	answering dept id	13
	answering dept short name	Environment, Food and Rural Affairs
	answering dept sort name	Environment, Food and Rural Affairs
	hansard heading	Bovine Tuberculosis: Disease Control
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what record they have of the annual financial cost of the badger culls in England over the past five years, and when a written value for money analysis of that cost was last undertaken.
	tabling member printed	Lord Banner
	uin	HL4262
	answer	answer is ministerial correction date of answer 10/05/2024 answer text <p>The cost of undertaking badger culling is paid for by industry. The Government pays for the licensing operation and monitoring, as well as the cost of policing culls.</p><p> </p><p>Information on the Government badger control costs for 2022 and previous years is available at GOV.UK. The Government badger control costs for 2023 will be published in due course.</p><p> </p><p>The most recent value for money analysis of the badger control policy was published on 28 October 2022. This can be found attached to this answer.</p> answering member printed Lord Douglas-Miller question first answered 10/05/2024 12:55:23 answering member 5006 label Biography information for Lord Douglas-Miller attachment 1 file name Badger control policy value for money analysis 2022.pdf title Badger control VFM analysis 2022
	tabling member	5014 label Biography information for Lord Banner